BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3329729)

  • 1. The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine.
    Davagnino J; Herrero M; Furlong D; Moreno F; Kolter R
    Proteins; 1986 Nov; 1(3):230-8. PubMed ID: 3329729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase.
    del Castillo FJ; del Castillo I; Moreno F
    J Bacteriol; 2001 Mar; 183(6):2137-40. PubMed ID: 11222617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli.
    Herrero M; Moreno F
    J Gen Microbiol; 1986 Feb; 132(2):393-402. PubMed ID: 3086495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP/GTP hydrolysis is required for oxazole and thiazole biosynthesis in the peptide antibiotic microcin B17.
    Milne JC; Eliot AC; Kelleher NL; Walsh CT
    Biochemistry; 1998 Sep; 37(38):13250-61. PubMed ID: 9748332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17.
    Genilloud O; Moreno F; Kolter R
    J Bacteriol; 1989 Feb; 171(2):1126-35. PubMed ID: 2644225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cofactor requirements and reconstitution of microcin B17 synthetase: a multienzyme complex that catalyzes the formation of oxazoles and thiazoles in the antibiotic microcin B17.
    Milne JC; Roy RS; Eliot AC; Kelleher NL; Wokhlu A; Nickels B; Walsh CT
    Biochemistry; 1999 Apr; 38(15):4768-81. PubMed ID: 10200165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification and expression of plasmid genes participating in the synthesis of microcin C51].
    Fomenko DE; Basiuk EI; Bezrukov VM; Volodin AA; Metlitskaia AZ; Khmel' IA
    Genetika; 1996 Oct; 32(10):1326-32. PubMed ID: 9091404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that colicin X is microcin B17.
    San Millán JL; Kolter R; Moreno F
    J Bacteriol; 1987 Jun; 169(6):2899-901. PubMed ID: 3034869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular structure of microcin H47 and colicin V.
    Azpiroz MF; Laviña M
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2412-9. PubMed ID: 17452478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of microcin B17 on microcin B17-immune cells.
    Herrero M; Kolter R; Moreno F
    J Gen Microbiol; 1986 Feb; 132(2):403-10. PubMed ID: 3519858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type Escherichia coli producing microcins B17, D93, J25, and L; cloning of genes for microcin L production and immunity.
    Sablé S; Duarte M; Bravo D; Lanneluc I; Pons AM; Cottenceau G; Moreno F
    Can J Microbiol; 2003 May; 49(5):357-61. PubMed ID: 12897830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and mapping of the genetic determinants for microcin B17 production and immunity.
    San Millan JL; Hernandez-Chico C; Pereda P; Moreno F
    J Bacteriol; 1985 Jul; 163(1):275-81. PubMed ID: 2989247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12.
    Laviña M; Pugsley AP; Moreno F
    J Gen Microbiol; 1986 Jun; 132(6):1685-93. PubMed ID: 3543211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cloning and analysis of genetic determinants determining the production of microcin B2 and B27].
    Basiuk EI; Bezrukov VM; Lipasova VA; Khmel' IA
    Genetika; 1994 Jun; 30(6):731-9. PubMed ID: 7958785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight post-translationally modified microcins.
    Severinov K; Semenova E; Kazakov A; Kazakov T; Gelfand MS
    Mol Microbiol; 2007 Sep; 65(6):1380-94. PubMed ID: 17711420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth phase and ompR regulation of transcription of microcin B17 genes.
    Hernández-Chico C; San Millán JL; Kolter R; Moreno F
    J Bacteriol; 1986 Sep; 167(3):1058-65. PubMed ID: 3017916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of posttranslational heterocycle biosynthesis in the gyrase inhibitor microcin B17: distance dependence from propeptide and tolerance for substitution in a GSCG cyclizable sequence.
    Sinha Roy R; Belshaw PJ; Walsh CT
    Biochemistry; 1998 Mar; 37(12):4125-36. PubMed ID: 9521734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria.
    Duquesne S; Petit V; Peduzzi J; Rebuffat S
    J Mol Microbiol Biotechnol; 2007; 13(4):200-9. PubMed ID: 17827970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli RNA polymerase is the target of the cyclopeptide antibiotic microcin J25.
    Delgado MA; Rintoul MR; Farías RN; Salomón RA
    J Bacteriol; 2001 Aug; 183(15):4543-50. PubMed ID: 11443089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.